Effect of methotrexate and leucovorin on female reproductive tract of albino rats

Cell Biochemistry and Function

Volumn 29, Issue 1, 2011, Pages 1-21

  Karri, Sritulasi ^a   Vanithakumari, G ^a  

^a BHARATHIAR UNIVERSITY   (India)

Author keywords

Enzymes; Female reproductive tract; Histopathology; Hormones; Leucovorin; Methotrexate; P450SCC; StAR protein

Indexed keywords

ALKALINE PHOSPHATASE; CYTOCHROME P450; DNA; ESTRADIOL; FOLINIC ACID; FOLLITROPIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LACTATE DEHYDROGENASE; METHOTREXATE; PROGESTERONE; RNA; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CHOLESTEROL SIDE CHAIN CLEAVAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTRUS CYCLE; FEMALE; FEMALE GENITAL SYSTEM; FOLLITROPIN BLOOD LEVEL; HISTOLOGY; IMMUNOBLOTTING; NONHUMAN; OVARY; OVARY FUNCTION; OVIDUCT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STEROIDOGENESIS; SUPPLEMENTATION; TISSUE STRUCTURE; UTERINE CERVIX; UTERUS; VAGINA;

ALKALINE PHOSPHATASE; ANIMALS; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GENITALIA, FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; L-LACTATE DEHYDROGENASE; LEUCOVORIN; LUTEINIZING HORMONE; METHOTREXATE; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; PHOSPHOPROTEINS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 78851469052     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1711     Document Type: Article

References (131)

1. Bertino JR. The mechanism of action of the folate antagonists in man. Cancer Res 1963; 23: 1286-1306.
2. Goldman ID. The mechanism of action of methotrexate. I. Interaction with a low-affinity intracellular site required for maximum inhibition of deoxyribonucleic acid synthesis in L-cell mouse fibroblasts. Mol Pharmacol 1974; 10: 257-274.
3. Jackson RC. Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 1984; 25: 61-82.
4. Skipper HE, Schabel FM, Jr, Wilcox WS. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep 1967; 51: 125-165.
5. Black RL, O'Brien WM, Vanscott EJ, Auerbach R, Eisen AZ, Bunim JJ. Methotrexate therapy in psoriatic arthritis; double-blind study on 21 patients. JAMA 1964; 189: 743-747.
6. Braun J, Baraliakos X. Treatment of ankylosing spondylitis and other spondyloarthritides. Curr Opin Rheumatol 2009; 21: 324-334.
7. De Moragas JM. Psoriasis and methotrexate. Rev Clin Esp 1965; 99: 122-126.
8. Stovall TG, Ling FW, Gray LA, Carson SA, Buster JE. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstet Gynecol 1991; 77: 749-753.
9. Shiina H, Oka K, Okane M, Tanno W, Kawasaki T, Nakayama M. Coexisting true hermaphroditism and partial hydatidiform mole developing metastatic gestational trophoblastic tumors. A case report. Virchows Arch 2002; 441: 514-518.
10. Karsdorp VH, Van der Veen F, Schats R, Boer-Meisel ME, Kenemans P. Successful treatment with methotrexate of five vital interstitial pregnancies. Hum Reprod 1992; 7: 1164-1169.
11. Trojano G, Colafiglio G, Saliani N, Lanzillotti G, Cicinelli E. Successful management of a cervical twin pregnancy: neoadjuvant systemic methotrexate and prophylactic high cervical cerclage before curettage. Fertil Steril 2009; 91: 935 93e 17-9.
12. Iqbal MP, Ahmed M, Umer M, Mehboobali N, Qureshi AA. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr 2003; 92: 1438-1444.
13. Aarsaether N, Berge RK, Aarsland A, Svardal A, Ueland PM. Effect of methotrexate on long-chain fatty acid metabolism in liver of rats fed a standard or a defined, choline-deficient diet. Biochim Biophys Acta 1988; 958: 70-80.
14. Costajde S, Lima RR. Metastases of choriocarcinoma treated with methotrexate and radiotherapy. Arq Bras Endocrinol Metabol 1963; 12: 39-48.
15. Pochedly C. Neurotoxicity due to CNS therapy for leukemia. Med Pediatr Oncol 1977; 3: 101-115.
16. Soga N, Arima K, Sugimura Y. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol 2008; 15: 800-803.
17. Averette HE, Boike GM, Jarrell MA. Effects of cancer chemotherapy on gonadal function and reproductive capacity. CA Cancer J Clin 1990; 40: 199-209.
18. Badri SN, Vanithakumari G, Malini T. Studies on methotrexate effects on testicular steroidogenesis in rats. Endocr Res 2000; 26: 247-262.
19. Chapman RM. Gonadal injury resulting from chemotherapy. Am J Ind Med 1983; 4: 149-161.
20. Padmanabhan S, Tripathi DN, Vikram A, Ramarao P, Jena GB. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid. Mutat Res 2009; 673: 43-52.
21. Albert A. Selective toxicity. In The Physico-chemical Basis of Therapy, Vol. 211. Clay R (ed.). The Chaucer Press: Bungay, Suffolk, UK, 1981; 309-313.
22. Zeisel SH. Choline deficiency. J Nutr Biochem 1990; 1: 332-349.
23. Erbe RE. Inborn errors of folate metabolism (first of two parts). N Engl J Med 1975; 293: 753-757.
24. Bertino JR, Levitt M, McCullough JL, Chabner B. New approaches to chemotherapy with folate antagonists: use of leucovorin 'rescue' and enzymic folate depletion. Ann N Y Acad Sci 1971; 186: 486-495.
25. Rosen G, Suwansirikul S, Kwon C, et al. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 1974; 33: 1151-1163.
26. Stover P, Schirch V. The metabolic role of leucovorin. Trends Biochem Sci 1993; 18: 102-106.
27. Black DJ, Livingston RB. Antineoplastic drugs in 1990. A review (Part I). Drugs 1990; 39: 489-501.
28. Sirotnak FM, Poser RE, Barrueco JR. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance. Cancer Res 1987; 47: 5334-5339.
29. Peters H. Folliculogenesis in mammals. In The Vertebrate Ovary. Jones RE (ed.). Plennum Press: New York, 1978; 121-140.
30. Pauerstein CJ, Woodruff JD, Zachary AS. Factors influencing physiologic activities in the fallopian tube; the anatomy, physiology, and pharmacology of tubal transport. Obstet Gynecol Surv 1968; 23: 215-243.
31. Barker KL, Rasmussen KR, Wheely S. Uterus and uterine response to estrogens. In Encyclopedia of Human Biology. Dulbecco R (ed.). Academic Press: San Diego, CA, 1991; 737-744.
32. Graham CE. Functional microanatomy of the uterine cervix. In Hand Book of Physiology, Section7: Endocrinology. Female Reproductive System, part 2, Vol. 2. Greep RO, Astwood EB (eds). American Physiology Society: Bethesda, MD, 1973; 375.
33. Thrasher JD, Clark FI, Clarke DR. Changes in the vaginal epithelial cell cyle in relation to events of the estrous cycle. Exp Cell Res 1967; 45: 232-236.
34. McCann SM, Porter JC. Hypothalamic pituitary stimulating and inhibiting hormones. Physiol Rev 1969; 49: 240-284.
35. Kronenberg MS, Clark JH. Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium. Endocrinology 1985; 117: 1480-1489.
36. Long JA, Evans HM. The oestrous cycle in the rat and its associated phenomena. Univ Calif 1922; 6: 148.
37. Knobil E, Neill J, Female reproductive system. In Physiology of Reproduction. Neill JD, Wassarman P (eds). Academic Press: San Diego, CA, 2005; 3296.
38. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994; 269: 28314-28322.
39. Ronen-Fuhrmann T, Timberg R, King SR, et al. Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 1998; 139: 303-315.
40. Clark BJ, Soo SC, Caron KM, Ikeda Y, Parker KL, Stocco DM. Hormonal and developmental regulation of the steroidogenic acute regulatory protein. Mol Endocrinol 1995; 9: 1346-1355.
41. Clark BJ, Stocco DM. Expression of the steroidogenic acute regulatory (StAR) protein: a novel LH-induced mitochondrial protein required for the acute regulation of steroidogenesis in mouse Leydig tumor cells. Endocr Res 1995; 21: 243-257.
42. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004; 25: 947-970.
43. Pon LA, Orme-Johnson NR. Acute stimulation of corpus luteum cells by gonadotrophin or adenosine 3', 5'-monophosphate causes accumulation of a phosphoprotein concurrent with acceleration of steroid synthesis. Endocrinology 1988; 123: 1942-1948.
44. Bose HS, Sugawara T, Strauss JF, 3rd, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 1996; 335: 1870-1878.
45. Sugawara T, Holt JA, Driscoll D, et al. Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci USA 1995; 92: 4778-4782.
46. Teng CS, Teng CT, Allfrey VG. Studies of nuclear acidic proteins. Evidence for their phosphorylation, tissue specificity, selective binding to deoxyribonucleic acid, and stimulation effects on transcription. J Biol Chem 1971; 246: 3597-3609.
47. Coffey DS, Barrack ER, Heston WD. The regulation of nuclear DNA template restrictions by acidic polymers. Adv Enzyme Regul 1974; 12: 219-266.
48. Luzzatto L, Battistuzzi G. Glucose-6-phosphate dehydrogenase. Adv Hum Genet 1985; 14: 86-88, 217-329.
49. Tsutsumi O, Satoh K, Sakamoto S. Studies on steroidogenesis in the oocyte. Nippon Naibunpi Gakkai Zasshi 1982; 58: 1321-1332.
50. Guraya SS. Biology of Ovarian Follicles in Mammals. Springer-Verlag: Berlin, 1985.
51. Moog F. Localization of alkaline phosphatase and acid phosphatase in early embryogenesis of the chick. Biol Bull Wood's Hole 1944; 86: 51-80.
52. Goode L, Warnick Aa, Wallae H. Alkaline and acid phosphatase activity in the endometrium and ovary of swine. J Anim Sci 1965; 24: 955-958.
53. Berenbaum MC, Brown IN. The effect of delayed administration of folinic acid on immunological inhibition by methotrexate. Immunology 1965; 8: 251-259.
54. Richards JS. Hormonal control of follicular growth and maturation in animals. In The Vertebrate Ovary: Comparitive Biology and Evolution. Jones RE (ed.). Plenum Press: New york, 1978; 331-360.
55. Lin KC, Kawamura N, Okamura H, Mori T. Inhibition of ovulation, steroidogenesis and collagenolytic activity in rabbits by sulpiride-induced hyperprolactinaemia. J Reprod Fertil 1988; 83: 611-618.
56. Sufi SB, Donaldson A, Jeffcoate SL. Method Manual, World Health Organization Collaborating Center for Research and Reference Services in the Immunoassay of Hormones in Human Reproduction. WHO, Geneva, Switzerland.
57. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495-496.
58. Bolten Aa, Hunter WM. Radioimmunoassay and related methods. In Immunochemistry, Vol. 1. Weir D, Herzenberg LA, Blakwell C (eds). Blackwell Scientific Publications: Boston, USA, 1990; 26.1-26.56.
59. Hotchkiss J, Atkinson LE, Knobil E. Time course of serum estrogen and luteinizing hormone (LH) concentrations during the menstrual cycle of the rhesus monkey. Endocrinology 1971; 89: 177-183.
60. Orczyk GP, Hichurs M, Arth G, Behrman HR. Methods of Hormone Radioimmunoassay. Academic Press: New York, 1974.
61. Mukku V, Moudgal NR. Studies on luteolysis: effect of antiserum to luteinizing hormone on sterols and steroid levels in pregnant hamsters. Endocrinology 1975; 97: 1455-1459.
62. Bancroft JD, Stevens A. Theory and Practice of Histological Techniques. Churchill Livingston Edinburgh: London and New York, 1977.
63. Hirshfield AN, Midgley AR Jr. Morphometric analysis of follicular development in the rat. Biol Reprod 1978; 19: 597-605.
64. Hanukoglu I, Spitsberg V, Bumpus JA, Dus KM, Jefcoate CR. Adrenal mitochondrial cytochrome P-450scc. Cholesterol and adrenodoxin interactions at equilibrium and during turnover. J Biol Chem 1981; 256: 4321-4328.
65. Epstein LF, Orme-Johnson NR. Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J Biol Chem 1991; 266: 19739-19745.
66. Christenson LK, Devoto L. Cholesterol transport and steroidogenesis by the corpus luteum. Reprod Biol Endocrinol 2003; 1: 90.
67. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
68. Karri S, Dertien JS, Stocco DM, Syapin PJ. Steroidogenic acute regulatory protein expression and pregnenolone synthesis in rat astrocyte cultures. J Neuroendocrinol 2007; 19: 860-869.
69. Mattson DL, Bellehumeur TG. Comparison of three chemiluminescent horseradish peroxidase substrates for immunoblotting. Anal Biochem 1996; 240: 306-308.
70. Karri S, Mclaurin S, Marshall D, Jumper C, Coimbatore G. Androgen treatment attenuates the expression of amyloid beta in the lungs of Alzheimer's transgenic mice. Indian J Gerontol 2009; 23: 113-132.
71. Karri S, Johnson H, Hendry WJ 3rd, Williams SC, Khan SA. Neonatal exposure to diethylstilbestrol leads to impaired action of androgens in adult male hamsters. Reprod Toxicol 2004; 19: 53-63.
72. Ikeda Y, Nagai A, Ikeda MA, Hayashi S. Neonatal estrogen exposure inhibits steroidogenesis in the developing rat ovary. Dev Dyn 2001; 221: 443-453.
73. Schneider W. Determination of nucleic acids in tissues by pentose analysis. Academic press: New York, 1957.
74. Ceriotti G. Determination of nucleic acids in animal tissues. J Biol Chem 1955; 214: 59-70.
75. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956; 62: 315-323.
76. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
77. Ryan KJ. Synthesis of Hormones in the Ovary. Williams & Wilkins: Baltimore, Maryland, 1963.
78. Henderson KA, Cupps PT. Acid and alkaline phosphatase in bovine antral follicles. J Anim Sci 1990; 68: 1363-1369.
79. Ryan RJ. Follicular Atresia: Some Speculations of Biochemical Markers and Mechanisms. Raven Press: New York, 1981.
80. King J. Practical Clinical Enzymology. D.Van Nostrand Company, Inc: Princeton, NJ, 1965.
81. Hunter F, Hagy GW. Interactions of tissue glucose-6-phosphate dehydrogenase (G6PD) activity with age and sexual development in the rat. Endokrinologie 1969; 54: 85-97.
82. Alcazar O, Tiedge M, Lenzen S. Importance of lactate dehydrogenase for the regulation of glycolytic flux and insulin secretion in insulin-producing cells. Biochem J 2000; 352(Pt 2): 373-380.
83. Andersch MA, Szczypinsk AJ. Use of p-nitrophenyl phosphate substrate in determination of serum acid phosphatase. Am J Clin PathoI 1947; 17: 571.
84. Bramley TA, Kent J. Mouse ovarian alkaline phosphatase activities that respond to gonadotropins: histochemical and biochemical studies. J Histochem Cytochem 1976; 24: 1101-1109.
85. Gol M, Saygili U, Koyuncuoglu M, Uslu T. Influence of high-dose methotrexate therapy on the primordial follicles of the mouse ovary. J Obstet Gynaecol Res 2009; 35: 429-433.
86. Djerassi I, Kim JS, Nayak N, Ohanissian H, Adler S, Hsieh S. New 'rescue' with massive doses of citrovorum factor for potentially lethal methotrexate toxicity. Cancer Treat Rep 1977; 61: 749-750.
87. Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010; 303: 1266-1273.
88. Perrotez C, Gebauer C, Menard A, et al. Tissue effects of methotrexate injected into the uterine horn of pregnant female rats. Hum Reprod 1991; 6: 480-483.
89. Savitskii GA, Ivanova RD, Nikitin AI, Nikolaichuk MP. Effect of methotrexate on the follicular apparatus of the ovary. Vopr Onkol 1977; 23: 84-86.
90. Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010; 116: 3102-3111.
91. Kroft J, Sabra S, Arthur R, Wolfman W. Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis. Gynecol Endocrinol 2010; 26: 179-180.
92. Lu JK, LaPolt PS, Nass TE, Matt DW, Judd HL. Relation of circulating estradiol and progesterone to gonadotropin secretion and estrous cyclicity in aging female rats. Endocrinology 1985; 116: 1953-1959.
93. Gray GD, Tennent B, Smith ER, Davidson JM. Luteinizing hormone regulation and sexual behavior in middle-aged female rats. Endocrinology 1980; 107: 187-194.
94. Nass TE, LaPolt PS, Judd HL, Lu JK. Alterations in ovarian steroid and gonadotrophin secretion preceding the cessation of regular oestrous cycles in ageing female rats. J Endocrinol 1984; 100: 43-50.
95. Rosowsky A, Wright JE, Ginty C, Uren J. Methotrexate analogues. 15. A methotrexate analogue designed for active-site-directed irreversible inactivation of dihydrofolate reductase. J Med Chem 1982; 25: 960-964.
96. Jarrell J, Lai EV, Barr R, McMahon A, Belbeck L, O'Connell G. Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat. Cancer Res 1987; 47: 2340-2343.
97. Sandberg JS, Goldin A. The use of leucovorin orally in normal and leukemic L1210 mice to prevent the toxicity and gastrointestinal lesions caused by high doses of methotrexate. Cancer Res 1970; 30: 1276-1280.
98. Hervey E, Hervey GR. The effects of progesterone on body weight and composition in the rat. J Endocrinol 1967; 37: 361-381.
99. Ashby JP, Shirling D, Baird JD. Differential changes in body composition during growth and progesterone treatment in intact female rats. J Endocrinol 1982; 93: 391-395.
100. Nunez AA, Gray JM, Wade GN. Food intake and adipose tissue lipoprotein lipase activity after hypothalamic estradiol benzoate implants in rats. Physiol Behav 1980; 25: 595-598.
101. Richards JS, Russell DL, Ochsner S, et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002; 57: 195-220.
102. Lerner LJ, Hilf R, Turkheimer AR, Michel I, Engel SL. Effects of hormone antagonists on morphological and biochemical changes induced by hormonal steroids in the immature rat uterus. Endocrinology 1966; 78: 111-124.
103. Graham CE. Uterine cervical epithelium of fetal and immature human females in relation to estrogenic stimulation. Am J Obstet Gynecol 1967; 97: 1033-1040.
104. Wise PM. Alterations in the proestrous pattern of median eminence LHRH, serum LH, FSH, estradiol and progesterone concentrations in middle-aged rats. Life Sci 1982; 31: 165-173.
105. Camp TA, Rahal JO, Mayo KE. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. Mol Endocrinol 1991; 5: 1405-1417.
106. Pakarainen T, Zhang FP, Nurmi L, Poutanen M, Huhtaniemi I. Knockout of luteinizing hormone receptor abolishes the effects of follicle-stimulating hormone on preovulatory maturation and ovulation of mouse graafian follicles. Mol Endocrinol 2005; 19: 2591-2602.
107. Channing CP. Studies on tissue culture of equine ovarian cell types: effect of gonadotrophins and stage of cycle on steroidogenesis. J Endocrinol 1969; 43: 415-425.
108. Donahue RP. Maturation of the mouse oocyte in vitro. I. Sequence and timing of nuclear progression. J Exp Zool 1968; 169: 237-249.
109. Shamberger RC, Sherins RJ, Rosenberg SA. The effects of postoperative adjuvant chemotherapy and radiotherapy on testicular function in men undergoing treatment for soft tissue sarcoma. Cancer 1981; 47: 2368-2374.
110. Schulz KD, Schmidt-Rhode P, Weymar P, Kunzig HJ, Geiger W. The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer. Arch Gynecol 1979; 227: 293-301.
111. Mehta RR, Beattie CW, Das Gupta TK. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 1992; 20: 125-132.
112. Richards JS, Hedin L. Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization. Annu Rev Physiol 1988; 50: 441-463.
113. Hirshfield AN, Midgley AR, Jr. The role of FSH in the selection of large ovarian follicles in the rat. Biol Reprod 1978; 19: 606-611.
114. Rosenfeld CS, Wagner JS, Roberts RM, Lubahn DB. Intraovarian actions of oestrogen. Reproduction 2001; 122: 215-226.
115. Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci 2004; 82(E-Suppl): E40-E52.
116. Natraj U, Richards JS. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 1993; 133: 761-769.
117. Rao MC, Midgley AR, Jr, Richards JS. Hormonal regulation of ovarian cellular proliferation. Cell 1978; 14: 71-78.
118. Shiromizu K, Thorgeirsson SS, Mattison DR. Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Pediatr Pharmacol (New York) 1984; 4: 213-221.
119. Cetin MT, Arisoy AH, Tap O, Kaya M, Urunsak I. Effects of methotrexate on the tubal morphology of rabbits: evaluation by electron microscopy. Gynecol Obstet Invest 2008; 65: 217-221.
120. Brenner RM, Slayden F. Cyclic changes in the primate oviduct and endometrium. In The Physiology of Reproduction. Knobil EaN JD (ed.). Raven Press: New York, 1994.
121. Jones RC, Edgren RA. The effects of various steroids on the vaginal histology in the rat. Fertil Steril 1973; 24: 284-291.
122. Juengel JL, Meberg BM, Turzillo AM, Nett TM, Niswender GD. Hormonal regulation of messenger ribonucleic acid encoding steroidogenic acute regulatory protein in ovine corpora lutea. Endocrinology 1995; 136: 5423-5429.
123. Oonk RB, Krasnow JS, Beattie WG, Richards JS. Cyclic AMP-dependent and -independent regulation of cholesterol side chain cleavage cytochrome P-450 (P-450scc) in rat ovarian granulosa cells and corpora lutea. cDNA and deduced amino acid sequence of rat P-450scc. J Biol Chem 1989; 264: 21934-21942.
124. Stocco DM, Clark BJ, Reinhart AJ, et al. Elements involved in the regulation of the StAR gene. Mol Cell Endocrinol 2001; 177: 55-59.
125. Holm J, Hansen SI, Hoier-Madsen M, Birn H, Helkjaer PE. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. Arch Biochem Biophys 1999; 366: 183-191.
126. Gorski J, Nelson NJ. Ribonucleic acid synthesis in the rat uterus and its early response to estrogen. Arch Biochem Biophys 1965; 110: 284-290.
127. Tata JR. Hormones and the synthesis and utilization of ribonucleic acids. Prog Nucleic Acid Res Mol Biol 1966; 5: 191-250.
128. Jungmann RA, Schweppe JS. Mechanism of action of gonadotropin. II. Control of ovarian nuclear ribonucleic acid polymerase activity and chromatin template capacity. J Biol Chem 1972; 247: 5543-5548.
129. Noteboom WD, Gorski J. An early effect of estrogen on protein synthesis. Proc Natl Acad Sci USA 1963; 50: 250-255.
130. Gelfant S, Meyer RK, Ris H. Uterine growth following stimulation by estrogen and inhibition by aminopterin and nitrogen mustard. J Exp Zool 1955; 128: 219-257.
131. Ho HY, Cheng ML, Lu FJ, et al. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic Biol Med 2000; 29: 156-169.